KALA BIO INC (KALA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.51-9.57%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · KALA
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -88.6% |
| Our one-year growth estimate | diamond | -60.0% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 28.6 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name is a smaller-cap name (higher miss base rate) and operates in a high-miss-rate industry. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 399 industry peers · Company calendar date is not available
KALA — legal / regulatory event — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standar…
Dated 2026-08-28
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 27, 2026, KALA BIO, Inc. (the “Company”) received a letter (the “Staff Determination Letter”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Staff has determined that the closing bid price of the Company’s common stock, par value $0.001 per share (the “Common Stock”), has been below $1.00 per share for…
Why it matters: How well the debt issuance goes can impact KALA's finances. It affects their ability to run operations.
Watch forKALA successfully raises at least $10 million through the debt issuance.
Also watch forKALA raises less than $5 million or fails to complete the debt issuance.
Why it matters: The reverse stock split aims to meet Nasdaq listing rules. A positive price reaction may signal investor confidence.
Supportive ifThe stock price stabilizes or increases above $1.00 per share after the split.
Worry ifThe stock price continues to decline below $1.00 per share after the split.
Why it matters: This license could drive future revenue growth. Progress will indicate success in the AI sector.
Supportive ifA new client or partnership is using the Younet AI platform.
Worry ifNo new clients or partnerships announced within the next quarter.
Why it matters: This license is a key growth strategy for KALA. Updates will show if the company is attracting clients.
Supportive ifKALA announces new client contracts. These contracts use the Younet AI platform.
Worry ifKALA reports no new clients or partnerships related to the AI platform within six months.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$443 on $10,000 · ±4.4% | How much price usually moves either way. |
| Bad day | $1,802 loss on $10,000 · 18.0% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,995 loss on $10,000 · 100.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: These sales may change how much shareholders earn. They can also impact the company's money.
Worry ifThere is an announcement about a new equity sale that raises a lot of money.
Less concerning ifThere have been no announcements about equity sales in over three months.
Why it matters: The debt issuance may affect cash flow and operational stability. Financial health is crucial for growth.
Worry ifThe financial report shows better cash flow or fewer losses after debt issuance.
Less concerning ifThe financial report shows worse cash flow or more losses after debt issuance.
Why it matters: The debt issuance could provide needed cash. Positive cash flow signals financial stability.
Supportive ifKALA reports improved cash flow in the next earnings report after the debt issuance.
Worry ifKALA reports continued cash flow issues in the next earnings report.
Why it matters: Changes to security holders' rights can change how money is used. This can affect investor trust.
Worry ifA press release explains the changes to security holders' rights.
Less concerning ifThere have been no updates on the changes for several months.
Why it matters: The reverse stock split aims to comply with Nasdaq rules. A stable or rising share price post-split is crucial for maintaining investor confidence.
Supportive ifKALA's share price remains above $1.00 for at least two weeks after the split.
Worry ifKALA's share price falls below $1.00 within two weeks after the split.
Why it matters: KALA needs to maintain its Nasdaq listing. Updates on compliance will indicate if the company is on track.
Watch forKALA gets confirmation from Nasdaq. It meets the listing rules after the split.
Also watch forKALA gets another notice of delisting from Nasdaq. This happens within three months after the split.